SS Innovations Marks Milestone in Robotic Surgery Adoption

SS Innovations International ( (SSII) ) has issued an update.

On May 5, 2026, SS Innovations International reported that more than 10,500 cumulative surgeries had been successfully completed using its SSi Mantra surgical robotic system as of April 30, 2026, spanning over 170 procedure types and including more than 500 cardiac, 170 telesurgery and 125 pediatric cases. Since the SSi Mantra’s commercial launch in August 2022, the company has installed over 200 systems across 11 countries and trained approximately 2,100 physicians, underscoring rapid adoption of its cost-focused, user-friendly platform and bolstering its position as a rising competitor in the global surgical robotics market.

Management highlighted that this procedural milestone in a short timeframe reflects the system’s technological differentiation and cost advantages, particularly in the vast Indian market where the company is headquartered, while its modular, multi-arm design and telesurgery capabilities are intended to broaden access to advanced robotic surgery. The growing installed base, clinical validation across more than 100 procedure types in India and expanding physician training footprint suggest strengthening operational momentum and increasing influence on how lower-cost robotic solutions may reshape access to surgical care in emerging and developed markets alike.

Spark’s Take on SSII Stock

According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.

The score is held down primarily by weak financial quality (ongoing losses and worsening cash burn) and a technically weak chart (trading below major moving averages with negative MACD). Positive corporate developments (approvals, installed-base growth, and new funding) provide meaningful support but do not fully offset profitability and cash-flow risks.

To see Spark’s full report on SSII stock, click here.

More about SS Innovations International

SS Innovations International, Inc. is a surgical robotics company that develops technologies aimed at making robotic surgery more affordable and accessible globally, with a particular focus on the Indian market and other international regions. Its portfolio centers on the proprietary SSi Mantra surgical robotic system and the complementary SSi Mudra suite of instruments, which support multi-specialty procedures including complex cardiac and pediatric surgeries.

Average Trading Volume: 71,054

Technical Sentiment Signal: Sell

Current Market Cap: $810.9M

See more insights into SSII stock on TipRanks’ Stock Analysis page.